Piper Sandler Expands Healthcare Investment Banking Team with the Addition of John Kerins
Piper Sandler Companies (NYSE: PIPR) has announced the appointment of John Kerins as managing director to their healthcare investment banking team. Based in New York, Kerins will focus on the pharma services sector. He brings 10 years of experience from Cain Brothers & Company, where he served as managing director in healthcare M&A, and six years at Deloitte in M&A advisory services.
J.P. Peltier, global group head of healthcare investment banking at Piper Sandler, highlighted Kerins' transaction experience and strong relationships with healthcare private equity funds as complementary assets to their practice. The appointment aligns with the firm's focus on pharma services, which they identify as a rapidly growing market segment.
Kerins holds a bachelor's degree from Kenyon College and an MBA from Fordham University Gabelli School of Business.
Piper Sandler Companies (NYSE: PIPR) ha annunciato la nomina di John Kerins come direttore generale del loro team di investment banking dedicato alla salute. Con sede a New York, Kerins si concentrerà sul settore dei servizi farmaceutici. Porta con sé 10 anni di esperienza da Cain Brothers & Company, dove ha ricoperto il ruolo di direttore generale nel M&A sanitario, e sei anni presso Deloitte nei servizi di consulenza M&A.
J.P. Peltier, responsabile globale del gruppo di investment banking sanitario in Piper Sandler, ha sottolineato l'esperienza nelle transazioni di Kerins e le solide relazioni con i fondi di private equity nel settore della salute come risorse complementari alla loro pratica. Questa nomina è in linea con il focus della società sui servizi farmaceutici, che identificano come un segmento di mercato in rapida crescita.
Kerins ha conseguito una laurea presso il Kenyon College e un MBA presso la Fordham University Gabelli School of Business.
Piper Sandler Companies (NYSE: PIPR) ha anunciado el nombramiento de John Kerins como director general de su equipo de banca de inversión en el sector de la salud. Con sede en Nueva York, Kerins se centrará en el sector de servicios farmacéuticos. Aporta 10 años de experiencia de Cain Brothers & Company, donde se desempeñó como director general en fusiones y adquisiciones en el sector salud, y seis años en Deloitte en servicios de asesoría de fusiones y adquisiciones.
J.P. Peltier, jefe global del grupo de banca de inversión en salud en Piper Sandler, destacó la experiencia transaccional de Kerins y sus sólidas relaciones con fondos de capital privado en el sector salud como activos complementarios a su práctica. El nombramiento se alinea con el enfoque de la firma en los servicios farmacéuticos, que identifican como un segmento de mercado en rápido crecimiento.
Kerins cuenta con una licenciatura del Kenyon College y un MBA de la Fordham University Gabelli School of Business.
파이퍼 샌들러 컴퍼니즈 (NYSE: PIPR)는 존 케린스를 헬스케어 투자은행 팀의 전무이사로 임명했다고 발표했습니다. 뉴욕에 본사를 두고 있는 케린스는 제약 서비스 부문에 집중할 예정입니다. 그는 케인 브라더스 & 컴퍼니에서 헬스케어 M&A의 전무이사로 재직한 10년의 경험과 딜로이트에서 M&A 자문 서비스로 6년 간의 경험을 가지고 있습니다.
파이퍼 샌들러의 헬스케어 투자은행 글로벌 그룹 책임자인 J.P. 펠티어는 케린스의 거래 경험과 헬스케어 프라이빗 에쿼티 펀드와의 강력한 관계를 그들의 실무에 보완하는 자산으로 강조했습니다. 이번 임명은 그들이 빠르게 성장하는 시장 세그먼트로 식별한 제약 서비스에 대한 회사의 초점과 일치합니다.
케린스는 케니언 칼리지에서 학사 학위를, 포드햄 대학교 가벨리 경영대학원에서 MBA를 취득했습니다.
Piper Sandler Companies (NYSE: PIPR) a annoncé la nomination de John Kerins au poste de directeur général de son équipe de banque d'investissement en santé. Basé à New York, Kerins se concentrera sur le secteur des services pharmaceutiques. Il apporte 10 années d'expérience de Cain Brothers & Company, où il a occupé le poste de directeur général en fusions et acquisitions dans le secteur de la santé, et six ans chez Deloitte dans les services de conseil en fusions et acquisitions.
J.P. Peltier, responsable mondial du groupe de banque d'investissement en santé chez Piper Sandler, a souligné l'expérience transactionnelle de Kerins et ses solides relations avec les fonds de capital-investissement en santé comme des atouts complémentaires à leur pratique. La nomination est en accord avec l'orientation de la société vers les services pharmaceutiques, qu'elle identifie comme un segment de marché en forte croissance.
Kerins est titulaire d'une licence du Kenyon College et d'un MBA de la Fordham University Gabelli School of Business.
Piper Sandler Companies (NYSE: PIPR) hat die Ernennung von John Kerins zum Managing Director ihres Healthcare-Investment-Banking-Teams angekündigt. Mit Sitz in New York wird Kerins sich auf den Bereich Pharma-Dienstleistungen konzentrieren. Er bringt 10 Jahre Erfahrung von Cain Brothers & Company mit, wo er als Managing Director im Bereich Healthcare M&A tätig war, sowie sechs Jahre bei Deloitte im Bereich M&A-Beratung.
J.P. Peltier, globaler Leiter des Healthcare-Investment-Banking bei Piper Sandler, hob die Transaktionserfahrung von Kerins sowie seine starken Beziehungen zu privaten Eigenkapitalfonds im Gesundheitsbereich als ergänzende Vermögenswerte für ihre Praxis hervor. Die Ernennung entspricht dem Fokus des Unternehmens auf Pharma-Dienstleistungen, die sie als schnell wachsenden Marktsegment identifizieren.
Kerins hat einen Bachelor-Abschluss vom Kenyon College und einen MBA von der Fordham University Gabelli School of Business.
- Strategic expansion into rapidly growing pharma services sector
- Addition of senior executive with 16+ years of healthcare M&A experience
- Enhancement of relationships with healthcare private equity funds
- None.
“We are excited to welcome John to the team. His transaction experience combined with strong relationships across the pharma services landscape and with the leading healthcare private equity funds investing in the category are highly complementary to our healthcare investment banking practice. Pharma services is a rapidly growing segment of the market and a key focus for our healthcare investment banking platform. We are confident John’s skillset will enhance our ability to serve our clients and position Piper Sandler for long-term success in this market,” said J.P. Peltier, global group head of healthcare investment banking at Piper Sandler.
Prior to joining the firm, Kerins spent 10 years at Cain Brothers & Company, most recently as a managing director on their healthcare team advising clients on mergers and acquisitions. Before that, he was an investment banker at Deloitte for six years providing M&A advisory services. He received his bachelor’s degree from Kenyon College and his Master of Business Administration degree from Fordham University Gabelli School of Business.
“I am thrilled to be joining Piper Sandler. Their healthcare investment banking team has a trusted reputation of M&A leadership in addition to their deep healthcare services and biopharma research presence. I look forward to working with my new partners to further drive best-in-class client service,” said Kerins.
ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the
Follow Piper Sandler: LinkedIn | Facebook | X
©2025. Since 1895. Piper Sandler Companies. 800 Nicollet Mall,
View source version on businesswire.com: https://www.businesswire.com/news/home/20250113878028/en/
Piper Sandler Companies
800 Nicollet Mall, Suite 900
CONTACT
Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com
Source: Piper Sandler Companies
FAQ
Who is John Kerins and what is his new role at Piper Sandler (PIPR)?
What is Piper Sandler's (PIPR) strategy in the pharma services sector?
What experience does John Kerins bring to Piper Sandler (PIPR)?
How will John Kerins' appointment impact Piper Sandler's (PIPR) healthcare investment banking practice?
